The presence of immune complexes (ICs) in sera is usually associated with a pathological process in the body. Several diseases are considered to be mediated by ICs. Among these are glomerulonephritis, some neoplastic, infectious, parasitic, autoimmune, and other diseases (13, 16, 17) . The ICs can directly mediate the pathological process at the target organ or may affect the immune system of the host, or they may act in both ways. Therefore, determination of the presence of ICs in sera could be an important factor in understanding the pathogenesis of the diseases and would also have a significant diagnostic value. The majority of these observations were obtained from the study of human diseases.
The purpose of this study was to determine the presence and frequency of the circulating ICs in sera from dogs with various diseases. Dogs are frequently used as a model for studying human diseases. Therefore, this research provides additional information about IC diseases in dogs and their applicability in studying IC disorders in humans. In this study, the mastocytoma cell assay was used in detecting circulating ICs (1 1).
MATERIALS AND METHODS Sera. Serum samples from 326 dogs of various species and ages with different diseases were obtained from the Veterinary Hospital, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio. Abnormalities in these dogs were detected by clinical examination, various laboratory tests, radiography, and histopathology. Diabetes mellitus in dogs was determined by clinical symptoms such as polyuria, polydipsia, polyphagia, emaciation, and detection of an elevation of blood sugar above 120 mg/100 ml and of a specific gravity of the urine of 1.040 to 0.060. The criteria for diagnosis of hypothyroidism were applied as previously described (4) . The ICs prepared in vitro. Various concentrations of ovalbumin ranging from 0.06 to 1 mg/ml were used to form complexes with canine anti-ovalbumin serum. The anti-ovalbumin serum, diluted 1:5, 1:10, 1:20 and 1:40, was mixed with an equal volume of various concentrations of ovalbumin. The mixtures were incubated in a water bath at 37°C for 40 min. The amount of precipitation in each tube was determined after overnight incubation at 4°C. The precipitate in the tubes was subsequently resuspended by sonication, and the concentration of ICs was determined for each tube.
The particulate ICs were prepared by mixing a 10% suspension of sheep erythrocytes with various dilutions of the canine anti-sheep erythrocyte serum (see the protocol for preparation of indicator cells). The erythrocytes that were sensitized with various dilutions of the canine serum were subsequently tested for their ability to form rosettes with P-815 mastocytoma cells, as described below. In some experiments, 50 ,ul of mastocytoma cells (5 x 106/ml) was mixed with an equal volume of sheep erythrocytes sensitized with canine anti-sheep erythrocyte serum (particulate ICs), and the mixture was centrifuged for 5 min at 500 x g. The rosette-forming cells were enumerated as above.
RESULTS
The binding of the ICs composed of canine IgG and its corresponding particulate or soluble antigens to the Fc receptors on mastocytoma cells was studied. (5) and L1210 leukemic cells (10) was described previously.
The binding of ICs composed of canine antiovalbumin and ovalbumin to mastocytoma cells indicated that the circulating ICs may also bind to mastocytoma cells. Therefore, the mastocytoma cell assay can be used to detect ICs in canine sera. Indeed, circulating ICs in dogs with hypothyroidism were previously determined by using the mastocytoma cell assay. (4) Twentyfive percent of sera from dogs with various disorders were positive for ICs in this study. Only ICs composed of IgG and corresponding antigen can be detected by this assay since mastocytoma cells do not possess receptors for the Fc portion of IgM or for complement. (2) In this study only inactivated sera were tested for the circulating IC. However, even the presence of the complement should not interfere with the binding of ICs of Fc receptors on mastocytoma cells as was previously determined (11) . It seems that the inactivation process did not induce aggregation of canine immunoglobulin because 47 of 50 control inactivated sera and canine anti-ovalbumin sera did not inhibit rosette formation with mastocytoma cells. The sera from control and sick dogs were stored, thawed, and inactivated in exactly the same manner.
In this study, only 6% of normal dogs possessed the circulating ICs. In contrast, no positive serum for ICs of 20 tested sera from normal dogs was reported by other investigators (10) . In the normal human population, the incidence of positive sera was from 0 to 15% (6, 14, 16 Generally, the percentage of sera with ICs in various canine diseases was similar to their counterparts of human diseases, such as hypothyroidism (1), filariasis (7), and hepatopathy (15) . Slightly higher percentages of sera with ICs were observed in diabetic dogs and dogs with arthritis or with nephropathy than in these human diseases (3, 9, 12) . However, this difference could be due to the small number of canine sera tested for ICs with these diseases. Approximately, 40% of dogs with neurological diseases had ICs in their sera. In five cases neuritis and in three cases undefined cause of seizure were diagnosed, which could be the effect of chronic distemper or other diseases affecting the nervous system.
In this study, ICs were detected in 37% of sera from dogs with various neoplastic diseases. Approximately 30% of the sera from dogs with mammary gland carcinoma or lymphosarcoma contained ICs. In patients with lymphosarcoma or mammary gland carcinoma, the incidence of positive sera was higher than in dogs with these tumors (6, 12) . In dogs with prostatomegaly, which might suggest preneoplastic changes, 50% of sera were positive. The incidence of circulating ICs in patients with prostatic carcinoma was lower than in dogs with prostatomegaly (12) .
Unfortunately, sera from dogs with such a typical IC disease as systemic lupus erythematosus or disease caused by the reaction to vaccination with canine adenovirus were not tested in this study. However, other investigators demonstrated ICs in sera from dogs with systemic lupus erythematosus (10) and dogs infected with canine adenovirus (8) .
The results of this study indicated the presence of ICs in sera from dogs with certain diseases. Further studies are presently being undertaken to determine deposition of ICs in various tissues, the origin of the antigen in the ICs, and their role in the pathogenesis of these diseases. Also, these results demonstrated the similarity in the frequency of occurrence of circulating ICs in canine and human diseases. Therefore, canine species may be used as a model to study the mechanism of development of IC diseases in humans.
